Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

PRK1 /PRK2 (pThr816) Antikörper (AbBy Fluor® 555)

Der Kaninchen Polyklonal Anti--Antikörper wurde für IF (cc) und IF (p) validiert. Er ist geeignet, in Proben von Human zu detektieren.
Produktnummer ABIN878546

Kurzübersicht für PRK1 /PRK2 (pThr816) Antikörper (AbBy Fluor® 555) (ABIN878546)

Target

PRK1 /PRK2

Reaktivität

Human

Wirt

  • 14
Kaninchen

Klonalität

  • 14
Polyklonal

Konjugat

  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
AbBy Fluor® 555

Applikation

  • 12
  • 12
  • 3
  • 3
  • 3
Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
  • Bindungsspezifität

    pThr816

    Homologie

    Human,Mouse,Rat,Dog,Cow,Pig,Horse,Rabbit

    Aufreinigung

    Purified by Protein A.

    Immunogen

    KLH conjugated synthetic phosphopeptide derived from human PRK1 around the phosphorylation site of Thr774

    Isotyp

    IgG
  • Applikationshinweise

    IF(IHC-P) 1:50-200
    IF(IHC-F) 1:50-200
    IF(ICC) 1:50-200

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1 μg/μL

    Buffer

    Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

    Konservierungsmittel

    ProClin

    Vorsichtsmaßnahmen

    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

    Lagerung

    -20 °C

    Informationen zur Lagerung

    Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

    Haltbarkeit

    12 months
  • Target

    PRK1 /PRK2

    Andere Bezeichnung

    PRK1 + PRK2

    Hintergrund

    Synonyms: Prokineticin-1/Endocrine-gland-derived vascular endothelial growth factor, PROK1, EGVEGF, PK1, EG-VEGF, PRK1.

    Background: Endocrine gland-derived vascular endothelial growth factor (EG-VEGF) induces proliferation, migration, and fenestration in capillary endothelial cells derived from endocrine glands. EG-VEGF possesses an HIF-1 binding site, its expression is induced by hypoxia and restricted to the steroidogenic glands (ovary, testis, adrenal and placenta). Expression of EG-VEGF is often complementary to the expression of VEGF, suggesting that these molecules function in a coordinated manner. EG-VEGF is an example of a class of highly specific mitogens that act to regulate proliferation and differentiation of the vascular endothelium in a tissue-specific manner. It is expressed primarily in one type of tissue and acts selectively on one type of endothelium. EG-VEGF, possibly through binding to a G protein-coupled receptor, results in the activation of MAPK p44/42 and phosphatidylinositol 3-kinase signaling pathways, leading to proliferation, migration and survival of responsive endothelial cells .

    Gen-ID

    5585
Sie sind hier:
Chat with us!